CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +249,749 | $12.00 | $3.0M | 1,302,600 |
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +207,672 | 207,672 | ||
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series A-2 Preferred Stock | −2,199,741 | 0 | ||
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series A-2 Preferred Stock | −425,497 | 0 | ||
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series A-2 Preferred Stock | −211,410 | 0 | ||
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −1,508,048 | 0 | ||
| 2022-05-10 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion · Series B Preferred Stock | −646,306 | 0 | ||
| 2022-05-10 | Flynn James E 10% owner | Conversion | +268,480 | 268,480 | ||
| 2022-05-10 | Flynn James E 10% owner | Conversion | +268,480 | 268,480 | ||
| 2022-05-10 | Flynn James E 10% owner | Purchase | +208,333 | $12.00 | $2.5M | 476,813 |
| 2022-05-10 | Flynn James E 10% owner | Purchase | +208,333 | $12.00 | $2.5M | 476,813 |
| 2022-05-10 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −273,313 | 0 | ||
| 2022-05-10 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −273,313 | 0 | ||
| 2022-05-10 | Oxford Science Enterprises plc 10% owner | Conversion | +1,262,986 | 1,381,846 | ||
| 2022-05-10 | Oxford Science Enterprises plc 10% owner | Conversion | +945,859 | 2,327,705 | ||
| 2022-05-10 | Oxford Science Enterprises plc 10% owner | Conversion | +1,547,713 | 3,875,418 | ||
| 2022-05-10 | Oxford Science Enterprises plc 10% owner | Conversion · Series A-1 Preferred stock | −1,285,720 | 0 | ||
| 2022-05-10 | Oxford Science Enterprises plc 10% owner | Conversion · Series A-2 Preferred stock | −962,884 | 0 | ||
| 2022-05-10 | Oxford Science Enterprises plc 10% owner | Conversion · Series B Preferred stock | −1,575,572 | 0 | ||
| 2022-05-06 | KEATING LAURIE Director | Purchase | +4,166 | $12.00 | $50K | 4,166 |
Page 10 of 11 · 211 trades